Holders — by stockHoldings — by fund
Krensavage Asset Management, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001609251
$265.4M
disclosed book value
20
positions
14.6%
largest position share
Positions, as of 2026-09-30
top 20 of 20 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | JAZZJAZZ PHARMACEUTICALS PLC | 167,816 | $38.9M | 14.6% |
| 2 | ENTAENANTA PHARMACEUTICALS INC | 2.9M | $37.8M | 14.2% |
| 3 | UTHRUNITED THERAPEUTICS CORP | 66,282 | $35.9M | 13.5% |
| 4 | BMRNBIOMARIN PHARMACEUTICAL INC | 524,786 | $31.5M | 11.9% |
| 5 | ABTABBOTT LABORATORIES | 200,000 | $19.8M | 7.4% |
| 6 | EXELEXELIXIS INC | 299,393 | $17.5M | 6.6% |
| 7 | RAREULTRAGENYX PHARMACEUTICAL IN | 1.1M | $17.1M | 6.5% |
| 8 | SUPNSUPERNUS PHARMACEUTICALS INC | 350,681 | $15.1M | 5.7% |
| 9 | SNYSANOFI-ADR | 333,946 | $13.8M | 5.2% |
| 10 | EMBCEMBECTA CORP | 1.1M | $6.4M | 2.4% |
| 11 | ARDXARDELYX INC | 1.8M | $6.2M | 2.3% |
| 12 | BNTXBIONTECH SE-ADR | 59,523 | $5.9M | 2.2% |
| 13 | VNDAVANDA PHARMACEUTICALS INC | 1.2M | $5.8M | 2.2% |
| 14 | GSKGSK PLC-SPON ADR | 96,729 | $4.7M | 1.8% |
| 15 | BIIBBIOGEN INC | 20,000 | $4.5M | 1.7% |
| 16 | INMDINMODE LTD | 120,942 | $1.7M | 0.6% |
| 17 | ANIPANI PHARMACEUTICALS INC | 13,000 | $944,000 | 0.4% |
| 18 | ACADACADIA PHARMACEUTICALS INC | 40,000 | $806,000 | 0.3% |
| 19 | ZTSZOETIS INC | 10,000 | $698,000 | 0.3% |
| 20 | EOLSEVOLUS INC | 57,985 | $464,000 | 0.2% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.